Biodexa Pharmaceuticals Plc
NASDAQBDRX short interest surges 149% in one week to 8,270 shares short, cost to borrow at 287% annually.
Snapshot as of 5 Jul 2026
No long-form analysis yet for BDRX. Pulse alerts and the live data picture are available on ORTEX.
Open BDRX on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BDRX — free to start on ORTEX.
Sign up for free →Open BDRX on ORTEX